NCT04938115View on ClinicalTrials.gov

Cell Therapy for CD7 Positive Acute Myeloid Leukemia or Mixed Lineage Leukemia

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 10, 2021

Primary Completion Date

May 31, 2023

Study Completion Date

October 30, 2023

Conditions
Leukemia, T Cell
Interventions
BIOLOGICAL

CD7 CART

Biological: CD7 CAR-T; Drug: Cyclophosphamide,Fludarabine; Procedure: Leukapheresis

Trial Locations (1)

Unknown

He bei Yan da Lu dao pei Hospital, Beijingcun

All Listed Sponsors
lead

Hebei Senlang Biotechnology Inc., Ltd.

INDUSTRY